
Study suggests extending tamoxifen treatment
December 5, 2012 4:29 PM
A new breast cancer study shows women who took tamoxifen for 10 years, instead of the recommended five, were 25 percent less likely to have a recurrence of the disease and 29 percent less likely to die. Elaine Quijano reports.
Change in use of breast cancer drug could save lives







